Literature DB >> 397005

Fractionation and characterization of Plasmodium falciparum antigens.

R J Wilson, I Ling.   

Abstract

In human malarial infections, the immunological importance of modified host cell components and of parasite antigens that may be released on spontaneous rupture of infected erythrocytes in vivo is not known. It is difficult, however, to analyse antigens extracted from entire parasitized red cells because of contamination with normal red cell constituents, notably haemoglobin. To overcome this problem, a simple chromatographic procedure has been developed that concentrates antigens and radiolabelled parasite products in a separate fraction from haemoglobin. Details are also given of investigations of two different kinds of antigen associated with Plasmodium falciparum. One antigen known to be immunogenic in man is shown to be associated with membranes. The other antigen is poorly immunogenic in man and other animals and is shown to be a soluble, rather stable, acidic protein.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397005      PMCID: PMC2395705     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  [Electrophoretic analysis of the non-haemoglobin proteins of human red cells].

Authors:  E BOTTINI; E R HUEHNS
Journal:  Clin Chim Acta       Date:  1963-01       Impact factor: 3.786

2.  Antigens associated with Plasmodium falciparum infections in man.

Authors:  R J Wilson; I A McGregor; P Hall; K Williams; R Bartholomew
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

3.  Demonstration of circulating antibodies to Plasmodium falciparum by gel-diffusion techniques.

Authors:  I A McGregor; P J Hall; K Williams; C L Hardy
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

4.  Radioactive labeling of proteins in vitro.

Authors:  R H Rice; G E Means
Journal:  J Biol Chem       Date:  1971-02-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The release of antigens by Plasmodium falciparum.

Authors:  R J Wilson; R K Bartholomew
Journal:  Parasitology       Date:  1975-10       Impact factor: 3.234

7.  Culture of Plasmodium falciparum in vitro: a subculture technique used for demonstrating antiplasmodial activity in serum from some Gambians, resident in an endemic malarious area.

Authors:  R S Phillips; P I Trigg; T J Scott-Finnigan; R K Bartholomew
Journal:  Parasitology       Date:  1972-12       Impact factor: 3.234

8.  Malarial S-antigens from man and owl monkey infected with Plasmodium falciparum.

Authors:  R J Wilson; A Voller
Journal:  Parasitology       Date:  1970-12       Impact factor: 3.234

9.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

  9 in total
  4 in total

1.  Concerted evolution at a multicopy locus in the protozoan parasite Theileria parva: extreme divergence of potential protein-coding sequences.

Authors:  R Bishop; A Musoke; S Morzaria; B Sohanpal; E Gobright
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Immunization of mice against blood-stage Plasmodium yoelii malaria with isoelectrically focused antigens and correlation of immunity with T-cell priming in vivo.

Authors:  J B De Souza; J H Playfair
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Diagnosis of Plasmodium falciparum infection using a solid-phase radioimmunoassay for the detection of malaria antigens.

Authors:  L Mackey; I A McGregor; P H Lambert
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

4.  Characterization of an S antigen synthesized by several isolates of Plasmodium falciparum.

Authors:  R F Anders; G V Brown; A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.